Literature DB >> 23027881

Multiple sclerosis and inflammatory bowel diseases: what we know and what we would need to know!

Mona M Alkhawajah1, Ana B Caminero, Hugh J Freeman, Joel J F Oger.   

Abstract

Multiple sclerosis (MS) is a demyelinating disorder of the central nervous system (CNS) but the causes have not been defined. The disease process appears to involve interplay between environmental factors and certain susceptibility genes. It is likely that the identification of the exact etiological mechanisms will permit the development of preventive and curative treatments. Evaluation of several diseases found to be more often associated than by chance alone may reveal clues to the etiology of those disorders. An association between MS and inflammatory bowel diseases (IBD) was suggested by the observation of an increased incidence of IBD among MS patients. A problem in the interpretation of the data rests, in part, with the observation that abnormal findings in brain magnetic resonance imaging (MRI) may be reported as MS in IBD patients. Defining the limits between incidental MRI findings and findings compatible with MS has resulted in further exploration of this possible association.

Entities:  

Mesh:

Year:  2012        PMID: 23027881     DOI: 10.1177/1352458512461393

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  8 in total

Review 1.  Multiple sclerosis and inflammatory bowel diseases: a systematic review and meta-analysis.

Authors:  Maria Kosmidou; Aristeidis H Katsanos; Konstantinos H Katsanos; Athanassios P Kyritsis; Georgios Tsivgoulis; Dimitrios Christodoulou; Sotirios Giannopoulos
Journal:  J Neurol       Date:  2016-11-22       Impact factor: 4.849

2.  Primary enteric-type mucinous adenocarcinoma of the urethra in a patient with ulcerative colitis.

Authors:  Dimitrios Dimitroulis; Dimitrios Patsouras; Athanasios Katsargyris; Petros Charalampoudis; Ioannis Anastasiou; Gregory Kouraklis
Journal:  Int Surg       Date:  2014 Sep-Oct

3.  A method for high purity intestinal epithelial cell culture from adult human and murine tissues for the investigation of innate immune function.

Authors:  Christina L Graves; Scott W Harden; Melissa LaPato; Michael Nelson; Byron Amador; Heather Sorenson; Charles J Frazier; Shannon M Wallet
Journal:  J Immunol Methods       Date:  2014-09-02       Impact factor: 2.303

4.  Intestinal barrier dysfunction develops at the onset of experimental autoimmune encephalomyelitis, and can be induced by adoptive transfer of auto-reactive T cells.

Authors:  Mehrnaz Nouri; Anders Bredberg; Björn Weström; Shahram Lavasani
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

5.  Viral Infection of the Central Nervous System Exacerbates Interleukin-10 Receptor Deficiency-Mediated Colitis in SJL Mice.

Authors:  Ann-Kathrin Uhde; Vanessa Herder; Muhammad Akram Khan; Malgorzata Ciurkiewicz; Dirk Schaudien; René Teich; Stefan Floess; Wolfgang Baumgärtner; Jochen Huehn; Andreas Beineke
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

6.  Neurological manifestations related to Crohn's disease: a boon for the workforce.

Authors:  Reza Nemati; Somayeh Mehdizadeh; Hooman Salimipour; Ehsan Yaghoubi; Zeinab Alipour; Seyed Masoud Tabib; Majid Assadi
Journal:  Gastroenterol Rep (Oxf)       Date:  2017-09-25

7.  Multiple sclerosis and inflammatory bowel disease: A systematic review and meta-analysis.

Authors:  Xuan Wang; Jian Wan; Min Wang; Yujie Zhang; Kaichun Wu; Fang Yang
Journal:  Ann Clin Transl Neurol       Date:  2022-01-29       Impact factor: 4.511

8.  Longer colonic transit time is associated with laxative and drug use, lifestyle factors, and symptoms of constipation.

Authors:  Johan Bohlin; Erik Dahlin; Julia Dreja; Bodil Roth; Olle Ekberg; Bodil Ohlsson
Journal:  Acta Radiol Open       Date:  2018-10-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.